Related Experiment Video
Updated: Jun 26, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
[Problems in the formation of tuberculosis epidemiological parameters]
Summary
This study analyzed 107,306 tuberculosis cases in Russia, revealing significant drug resistance (DR) and multidrug resistance (MDR) rates, particularly in relapsed cases. Reporting systems require improvement for effective tuberculosis epidemic monitoring.
Area of Science:
- Epidemiology
- Microbiology
- Public Health
Context:
- Analysis of 107,306 tuberculosis (TB) cases and relapses in the Russian Federation (RF).
- Evaluation of data completeness and validity against Russian Statistics Committee's form 8.
- Assessment of treatment efficacy and TB epidemic monitoring within RF health facilities.
Purpose:
- To analyze the prevalence of drug resistance (DR) and multidrug resistance (MDR) in new and relapsed TB cases in Russia.
- To evaluate the effectiveness of current TB reporting and diagnostic practices.
- To identify areas for improvement in TB surveillance and management.
Summary:
- Bacterial discharge observed in 33.3% (microscopy) to 44.9% (cultures) of new TB cases; cavities in 42.6%.
- Drug resistance (DR) detected in 30.6% of new cases and 45.4% of relapsed cases. Multidrug resistance (MDR) found in 11.4% of new cases and 24.7% of relapsed cases.
- Coverage for Mycobacterium tuberculosis susceptibility testing was 76.3-83.1%. Detection rate of infectious patients in general facilities was low (12.5%).
Impact:
- Highlights the urgent need to improve TB reporting documentation (Order No. 50) for accurate epidemic evaluation.
- Stresses the necessity of uniform calculation rules for all RF reporting forms, especially for DR-TB indicators.
- Underscores the inadequate and variable efficiency of microbiological studies across RF federal districts, impacting patient management and control efforts.
Related Concept Videos
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...